Polyelectrolyte thromboresistant affinity coatings for modification of devices contacting blood

The modification of hydrophobic polyethylene/polystyrene surfaces of medical devices with bilayer/multilayer coatings (BCs/MCs) based on polyelectrolyte complexes (PEC) of modified poly(N‐vinylpyrrolidone‐co‐maleic acid) copolymer (VPMA) with chitosan, amphiphilic chitosan, or albumin was studied. T...

Full description

Saved in:
Bibliographic Details
Published inJournal of biomedical materials research. Part A Vol. 82A; no. 3; pp. 589 - 598
Main Authors Samoilova, Nadezhda A., Krayukhina, Maria A., Novikova, Svetlana P., Babushkina, Tatyana A., Volkov, Iliya O., Komarova, Lidiya I., Moukhametova, Liliya I., Aisina, Roza B., Obraztsova, Ekaterina A., Yaminsky, Igor V., Yamskov, Igor A.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.09.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The modification of hydrophobic polyethylene/polystyrene surfaces of medical devices with bilayer/multilayer coatings (BCs/MCs) based on polyelectrolyte complexes (PEC) of modified poly(N‐vinylpyrrolidone‐co‐maleic acid) copolymer (VPMA) with chitosan, amphiphilic chitosan, or albumin was studied. The VPMA contained l‐Lysine as affinity ligand for plasminogen attached through α‐amino group. The surface properties and chemical composition of the surfaces investigated were analyzed, using sessile‐drop water contact angle measurements, attenuated total reflectance Fourier‐transform infrared spectroscopy (ATR‐FTIR), X‐ray photoelectron spectroscopy (XPS), and atomic force microscopy (AFM). The specific adsorption of plasminogen (precursor of fibrinolytic enzyme plasmin) from its solutions and from human blood plasma on the modified surfaces was investigated. It was established that polyelectrolyte MCs are more efficient than single‐layer BCs and the affine polymer coatings without interlayer. A thrombogenicity decrease for the materials modified with BCs and MCs was shown in in vitro and ex vivo trials. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res 2007
Bibliography:ark:/67375/WNG-KBWMT291-8
RFBR - No. RFBR 04-03-32473
istex:0C315FCA2731E69B089BD1052849FB230AF6717B
INTAS - No. INTAS 06-109-4966
ArticleID:JBM31178
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1549-3296
1552-4965
DOI:10.1002/jbm.a.31178